Around 5%–10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months or more.

In the face of the relentless threat posed by highly pathogenic RNA viruses, such as SARS-CoV-2, HIV, and avian influenza, the quest for innovative antiviral therapies has never been more urgent.

Scientists have discovered a surprising silver lining of COVID-19 infection. A new study by researchers at Northwestern ...

The COVID-19 virus may come with a surprising benefit. It may have the ability to shrink certain cancerous tumors, according ...

A virus is, arguably, the smallest possible living thing. It is a bundle of DNA or RNA bound up in a minuscule core, sometimes surrounded by a sturdy envelope and sometimes not. It can reproduce, but ...

RNA from the COVID-19 infection in patients with certain metastatic cancers may be associated with tumor shrinkage, but more ...

A study led by Liverpool School of Tropical Medicine (LSTM) used cutting-edge bioinformatic data mining techniques to identify 91 RNA viruses in 28 species of parasitic nematodes, representing 70% of ...

A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

According to a recent study, Covid-19 may unanticipatedly help cancer patients by reducing malignant tumors, which may result ...

Once inside the body, HIV persists because of its remarkable ability to hide within healthy CD4 T cells, where it can lie ...